DelfaGLP-1 Atlas

Lead sponsor

Chinese University of Hong Kong

4 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

4

Trials led

3

Active

490

Total enrollment

4

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 2
3
Phase 4
1

Trials by status

Not yet recruiting
2
Recruiting
1
Completed
1

Trials led

GLICH—Ph 2Not yet recruiting200
GALLOP—Ph 2Completed140
GAPP-SVD—Ph 2Recruiting110
GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic ArthritisBMI ≥25Ph 4Not yet recruiting40